Abeona Therapeutics ABEO
$ 5.9
2.52%
Quarterly report 2024-Q3
added 11-14-2024
Abeona Therapeutics Cash Flow 2011-2024 | ABEO
Annual Cash Flow Abeona Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-37 M | -43.5 M | -65.7 M | -35 M | -62.8 M | -39.1 M | -22.7 M | -13 M | - | - | 1 K | -3.96 M | -7.61 M |
Depreciation & Amortization |
2.29 M | 3.09 M | 3.25 M | 4.59 M | 7.82 M | 2.36 M | 741 K | 825 K | 551 K | 11 K | 3 K | 419 K | 233 K |
Accounts Payables |
1.86 M | 1.81 M | 4.32 M | 4.7 M | 3.76 M | 6.12 M | 2.39 M | 3.69 M | 875 K | 1.9 M | 863 K | 2.04 M | 1.71 M |
Accounts Receivables |
- | - | 3 M | - | - | 81 K | 107 K | 124 K | 115 K | 35 K | 74 K | 840 K | 333 K |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | 194 K | 151 K |
All numbers in USD currency
Quarterly Cash Flow Abeona Therapeutics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -14.5 M | - | - | - | -11.7 M | - | -29.5 M | -22.7 M | -13.7 M | - | -35.4 M | -25.1 M | -13.6 M | - | -33.4 M | -22.7 M | -13.2 M | - | -48.6 M | -30.3 M | -15.1 M | - | -22.1 M | -13.1 M | -4.08 M | - | -17.6 M | -10.8 M | -5.86 M | - | -9.62 M | - | - | - | - | - | - | - | - | - | -125 K | - | 475 K | 1.39 M | -346 K | - | -2.34 M | -1.86 M | -1.08 M | - | -5.64 M | -2.65 M | -837 K |
Depreciation & Amortization |
500 K | 500 K | 491 K | - | 500 K | 600 K | 661 K | - | 800 K | 800 K | 811 K | - | 2.44 M | 1.64 M | 817 K | - | 847 K | 834 K | 2.06 M | - | 2.03 M | 2.06 M | 1.66 M | - | 505 K | 290 K | 174 K | - | 138 K | 207 K | 250 K | - | 222 K | 181 K | 174 K | - | 151 K | 132 K | 118 K | - | 1 K | 1 K | - | - | - | 1 K | 1 K | 29 K | 18 K | 19 K | 54 K | - | 56 K | 59 K | 61 K |
Accounts Payables |
2.79 M | 3.1 M | 3.36 M | 1.86 M | 2.59 M | 3.48 M | 2.86 M | 1.81 M | 1.75 M | 1.74 M | 1.6 M | 4.32 M | 1.86 M | 1.47 M | 2.48 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 3.76 M | 3.76 M | 3.76 M | 3.76 M | 6.12 M | 6.12 M | 6.12 M | 6.12 M | 1.88 M | 2.39 M | 2.39 M | 2.39 M | 3.69 M | 3.69 M | 3.69 M | 3.69 M | 875 K | 875 K | 875 K | 875 K | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 863 K | 863 K | 863 K | 863 K | 2.04 M | 2.04 M | 2.04 M | 2.04 M | 1.71 M | 1.71 M | 1.71 M | 1.71 M |
Accounts Receivables |
- | - | - | - | - | 3.5 M | - | - | 1.05 M | 1 M | - | 3 M | - | - | - | - | 7 M | - | - | - | 15 K | 40 K | 38 K | 81 K | 81 K | 81 K | 81 K | 107 K | 107 K | 107 K | 107 K | 124 K | 124 K | 124 K | 124 K | 115 K | 115 K | 115 K | 115 K | 35 K | 35 K | 35 K | 35 K | 74 K | 74 K | 74 K | 74 K | 840 K | 840 K | 840 K | 840 K | 333 K | 333 K | 333 K | 333 K |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 150 K | 194 K | 194 K | 194 K | 194 K | 151 K | 151 K | 151 K | 151 K |
All numbers in USD currency